| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear speck | 3.48e-05 | 431 | 45 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 1.10e-04 | 903 | 45 | 9 | GO:0016604 | |
| Domain | EPHD | 1.70e-05 | 22 | 43 | 3 | PS51805 | |
| Domain | PHD | 5.16e-05 | 89 | 43 | 4 | SM00249 | |
| Domain | Znf_PHD | 5.63e-05 | 91 | 43 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.66e-05 | 95 | 43 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.94e-05 | 96 | 43 | 4 | PS01359 | |
| Domain | Znf_FYVE_PHD | 3.58e-04 | 147 | 43 | 4 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 4.49e-04 | 65 | 43 | 3 | IPR019786 | |
| Domain | PHD | 6.84e-04 | 75 | 43 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 7.96e-04 | 79 | 43 | 3 | IPR019787 | |
| Domain | Ank_2 | 1.48e-03 | 215 | 43 | 4 | PF12796 | |
| Domain | Ank | 1.84e-03 | 228 | 43 | 4 | PF00023 | |
| Domain | Helicase_C | 1.91e-03 | 107 | 43 | 3 | PF00271 | |
| Domain | HELICc | 1.91e-03 | 107 | 43 | 3 | SM00490 | |
| Domain | Helicase_C | 1.96e-03 | 108 | 43 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.01e-03 | 109 | 43 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.01e-03 | 109 | 43 | 3 | PS51192 | |
| Domain | SNF2_N | 2.46e-03 | 32 | 43 | 2 | PF00176 | |
| Domain | SNF2_N | 2.46e-03 | 32 | 43 | 2 | IPR000330 | |
| Domain | - | 2.49e-03 | 248 | 43 | 4 | 1.25.40.20 | |
| Domain | ANK | 2.60e-03 | 251 | 43 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 2.68e-03 | 253 | 43 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.72e-03 | 254 | 43 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.72e-03 | 254 | 43 | 4 | PS50297 | |
| Domain | Ankyrin_rpt | 3.04e-03 | 262 | 43 | 4 | IPR002110 | |
| Domain | BROMODOMAIN_1 | 3.28e-03 | 37 | 43 | 2 | PS00633 | |
| Domain | BROMODOMAIN_2 | 4.01e-03 | 41 | 43 | 2 | PS50014 | |
| Domain | BROMO | 4.20e-03 | 42 | 43 | 2 | SM00297 | |
| Domain | Bromodomain | 4.20e-03 | 42 | 43 | 2 | IPR001487 | |
| Domain | - | 4.20e-03 | 42 | 43 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_MRNA_SPLICING | 6.49e-05 | 212 | 29 | 5 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.52e-04 | 283 | 29 | 5 | M13087 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 3.43e-04 | 67 | 29 | 3 | M27694 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.29e-04 | 724 | 29 | 7 | M16843 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.67e-04 | 84 | 29 | 3 | M725 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.20e-04 | 201 | 29 | 4 | MM15411 | |
| Pubmed | Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells. | 8.65e-09 | 4 | 46 | 3 | 14578391 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF11 NKTR PRPF38A SRSF4 MCPH1 SRRM2 PNISR SP110 RNPS1 CDK13 NTHL1 BCORL1 | 8.06e-08 | 1294 | 46 | 12 | 30804502 |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 3.55e-07 | 11 | 46 | 3 | 14729963 | |
| Pubmed | 3.82e-07 | 723 | 46 | 9 | 34133714 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.74e-07 | 774 | 46 | 9 | 15302935 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 9.53e-07 | 807 | 46 | 9 | 22681889 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.17e-06 | 259 | 46 | 6 | 30404004 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.21e-06 | 608 | 46 | 8 | 36089195 | |
| Pubmed | KIAA1549 CHD9 ZNF469 RESF1 SRRM2 SP110 RNPS1 NOTCH2 BRPF1 AGAP3 | 1.58e-06 | 1116 | 46 | 10 | 31753913 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 7.92e-06 | 361 | 46 | 6 | 26167880 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KNDC1 CHD9 SRSF11 MCPH1 ADARB1 CDK13 TTLL11 NOTCH2 KDM4B AGAP3 | 2.00e-05 | 1489 | 46 | 10 | 28611215 |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 2.56e-05 | 6 | 46 | 2 | 17361132 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 8617202 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 9531537 | ||
| Pubmed | 4.74e-05 | 300 | 46 | 5 | 28561026 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 19857271 | ||
| Pubmed | 8.92e-05 | 1103 | 46 | 8 | 34189442 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 9.55e-05 | 180 | 46 | 4 | 30110629 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 1.32e-04 | 13 | 46 | 2 | 20516191 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.35e-04 | 197 | 46 | 4 | 22365833 | |
| Pubmed | 2.54e-04 | 1285 | 46 | 8 | 35914814 | ||
| Pubmed | 2.61e-04 | 234 | 46 | 4 | 36243803 | ||
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 2.67e-04 | 94 | 46 | 3 | 37468549 | |
| Pubmed | Genome-wide association study of chronic periodontitis in a general German population. | 2.84e-04 | 96 | 46 | 3 | 24024966 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 2.84e-04 | 96 | 46 | 3 | 25948554 | |
| Pubmed | 2.88e-04 | 19 | 46 | 2 | 25263594 | ||
| Pubmed | 3.39e-04 | 713 | 46 | 6 | 29802200 | ||
| Pubmed | 3.59e-04 | 104 | 46 | 3 | 9205841 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 3.90e-04 | 107 | 46 | 3 | 20508642 | |
| Pubmed | 4.12e-04 | 109 | 46 | 3 | 12226669 | ||
| Pubmed | 4.82e-04 | 115 | 46 | 3 | 17332742 | ||
| Pubmed | 5.48e-04 | 1442 | 46 | 8 | 35575683 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.15e-04 | 125 | 46 | 3 | 32891193 | |
| Pubmed | 6.89e-04 | 130 | 46 | 3 | 12421765 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 9.49e-04 | 330 | 46 | 4 | 33301849 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.00e-03 | 877 | 46 | 6 | 20211142 | |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 1.08e-03 | 342 | 46 | 4 | 23455924 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.12e-03 | 154 | 46 | 3 | 16055720 | |
| Pubmed | 1.14e-03 | 347 | 46 | 4 | 16033648 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 1.17e-03 | 38 | 46 | 2 | 19608861 | |
| Pubmed | 1.18e-03 | 1247 | 46 | 7 | 27684187 | ||
| Interaction | DHX8 interactions | 2.86e-07 | 292 | 46 | 8 | int:DHX8 | |
| Interaction | SRSF11 interactions | 3.64e-07 | 203 | 46 | 7 | int:SRSF11 | |
| Interaction | SRRM4 interactions | 1.48e-06 | 37 | 46 | 4 | int:SRRM4 | |
| Interaction | NKAPD1 interactions | 1.70e-06 | 161 | 46 | 6 | int:NKAPD1 | |
| Interaction | ZNF777 interactions | 3.17e-06 | 100 | 46 | 5 | int:ZNF777 | |
| Interaction | SRPK2 interactions | SRSF11 NKTR PRPF38A SRSF4 SRRM2 PNISR ADARB1 RNPS1 CDK13 NTHL1 | 3.90e-06 | 717 | 46 | 10 | int:SRPK2 |
| Interaction | SRSF4 interactions | 4.92e-06 | 300 | 46 | 7 | int:SRSF4 | |
| Interaction | CLK2 interactions | 5.16e-06 | 195 | 46 | 6 | int:CLK2 | |
| Interaction | PIP4K2A interactions | 9.26e-06 | 216 | 46 | 6 | int:PIP4K2A | |
| Interaction | DDX23 interactions | 1.15e-05 | 480 | 46 | 8 | int:DDX23 | |
| Interaction | ZCCHC10 interactions | 1.53e-05 | 236 | 46 | 6 | int:ZCCHC10 | |
| Interaction | CEBPA interactions | RPGRIP1 CHD9 MLLT6 ATF5 RESF1 RAD54L2 SRRM2 SP110 RNPS1 CDK13 ZNF174 BCORL1 | 1.60e-05 | 1245 | 46 | 12 | int:CEBPA |
| Interaction | LUC7L interactions | 1.77e-05 | 242 | 46 | 6 | int:LUC7L | |
| Interaction | ZSCAN25 interactions | 2.30e-05 | 73 | 46 | 4 | int:ZSCAN25 | |
| Interaction | SRSF7 interactions | 4.65e-05 | 425 | 46 | 7 | int:SRSF7 | |
| Interaction | RNPS1 interactions | 4.65e-05 | 425 | 46 | 7 | int:RNPS1 | |
| Interaction | NKTR interactions | 5.26e-05 | 90 | 46 | 4 | int:NKTR | |
| Interaction | PNN interactions | 6.10e-05 | 302 | 46 | 6 | int:PNN | |
| Interaction | SRPK3 interactions | 7.08e-05 | 190 | 46 | 5 | int:SRPK3 | |
| Interaction | PRP4K interactions | 9.77e-05 | 329 | 46 | 6 | int:PRP4K | |
| Interaction | SON interactions | 1.08e-04 | 208 | 46 | 5 | int:SON | |
| Interaction | ZNF646 interactions | 1.20e-04 | 42 | 46 | 3 | int:ZNF646 | |
| Interaction | RSBN1L interactions | 1.32e-04 | 114 | 46 | 4 | int:RSBN1L | |
| Interaction | SRSF6 interactions | 1.33e-04 | 503 | 46 | 7 | int:SRSF6 | |
| Interaction | CLK1 interactions | 1.38e-04 | 219 | 46 | 5 | int:CLK1 | |
| Interaction | SLC40A1 interactions | 1.41e-04 | 8 | 46 | 2 | int:SLC40A1 | |
| Interaction | SRRM3 interactions | 1.41e-04 | 8 | 46 | 2 | int:SRRM3 | |
| Interaction | CAMKV interactions | 1.51e-04 | 118 | 46 | 4 | int:CAMKV | |
| Interaction | CDK12 interactions | 1.67e-04 | 228 | 46 | 5 | int:CDK12 | |
| Interaction | SRSF3 interactions | 1.68e-04 | 522 | 46 | 7 | int:SRSF3 | |
| Interaction | CD2BP2 interactions | 1.81e-04 | 232 | 46 | 5 | int:CD2BP2 | |
| Interaction | RNF217 interactions | 1.82e-04 | 9 | 46 | 2 | int:RNF217 | |
| Interaction | PPIG interactions | 2.00e-04 | 127 | 46 | 4 | int:PPIG | |
| Interaction | PNISR interactions | 2.15e-04 | 51 | 46 | 3 | int:PNISR | |
| Interaction | NKAP interactions | 2.32e-04 | 132 | 46 | 4 | int:NKAP | |
| Interaction | H3-3A interactions | 2.62e-04 | 749 | 46 | 8 | int:H3-3A | |
| Interaction | H2BC17 interactions | 2.90e-04 | 140 | 46 | 4 | int:H2BC17 | |
| Interaction | ZNF483 interactions | 3.31e-04 | 59 | 46 | 3 | int:ZNF483 | |
| Interaction | SNIP1 interactions | 3.52e-04 | 417 | 46 | 6 | int:SNIP1 | |
| Interaction | ZNF771 interactions | 3.65e-04 | 61 | 46 | 3 | int:ZNF771 | |
| Interaction | PRDM10 interactions | 4.21e-04 | 64 | 46 | 3 | int:PRDM10 | |
| Interaction | PPIE interactions | 4.44e-04 | 282 | 46 | 5 | int:PPIE | |
| Interaction | USP42 interactions | 4.60e-04 | 66 | 46 | 3 | int:USP42 | |
| Interaction | NUP43 interactions | 4.99e-04 | 625 | 46 | 7 | int:NUP43 | |
| Interaction | ACIN1 interactions | 5.97e-04 | 301 | 46 | 5 | int:ACIN1 | |
| Interaction | C1orf35 interactions | 6.24e-04 | 304 | 46 | 5 | int:C1orf35 | |
| Interaction | ZNF689 interactions | 6.44e-04 | 74 | 46 | 3 | int:ZNF689 | |
| Interaction | SRPK1 interactions | 7.15e-04 | 477 | 46 | 6 | int:SRPK1 | |
| Interaction | RBM25 interactions | 8.20e-04 | 323 | 46 | 5 | int:RBM25 | |
| Cytoband | 16p13.3 | 1.07e-04 | 244 | 46 | 4 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 8.77e-04 | 426 | 46 | 4 | chr16p13 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.86e-04 | 12 | 31 | 2 | 737 | |
| GeneFamily | PHD finger proteins | 4.85e-04 | 90 | 31 | 3 | 88 | |
| GeneFamily | Ankyrin repeat domain containing | 7.42e-04 | 242 | 31 | 4 | 403 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.44e-03 | 51 | 31 | 2 | 870 | |
| GeneFamily | RNA binding motif containing | 5.68e-03 | 213 | 31 | 3 | 725 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 1.08e-06 | 807 | 46 | 10 | M16651 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 2.55e-05 | 199 | 46 | 5 | M4460 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.71e-05 | 152 | 45 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 2.32e-05 | 162 | 45 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ETAA1 KIAA1549 CHD9 CLIP3 SRSF11 EFCAB14 MCPH1 NRCAM PNISR SUPV3L1 KDM4B | 4.70e-05 | 1257 | 45 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.23e-04 | 230 | 45 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.77e-04 | 249 | 45 | 5 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ETAA1 KIAA1549 CHD9 CLIP3 SRSF11 EFCAB14 MCPH1 NRCAM PNISR SUPV3L1 KDM4B | 1.79e-04 | 1459 | 45 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.99e-04 | 404 | 45 | 6 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.04e-04 | 406 | 45 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.24e-04 | 413 | 45 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.10e-04 | 281 | 45 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.30e-04 | 629 | 45 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.43e-09 | 200 | 46 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-06 | 191 | 46 | 5 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.81e-06 | 197 | 46 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.90e-06 | 199 | 46 | 5 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-06 | 200 | 46 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 140 | 46 | 4 | a88dbe7bf3e1419e360ab0b8cf24681d3424c3a7 | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 1.88e-05 | 153 | 46 | 4 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.98e-05 | 155 | 46 | 4 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.35e-05 | 162 | 46 | 4 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-05 | 170 | 46 | 4 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 2.90e-05 | 171 | 46 | 4 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.86e-05 | 184 | 46 | 4 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.29e-05 | 189 | 46 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.47e-05 | 191 | 46 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.56e-05 | 192 | 46 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 4.65e-05 | 193 | 46 | 4 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.75e-05 | 194 | 46 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.84e-05 | 195 | 46 | 4 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.84e-05 | 195 | 46 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.04e-05 | 197 | 46 | 4 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.04e-05 | 197 | 46 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.04e-05 | 197 | 46 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.04e-05 | 197 | 46 | 4 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.04e-05 | 197 | 46 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.24e-05 | 199 | 46 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.24e-05 | 199 | 46 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 5.24e-05 | 199 | 46 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 46 | 4 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.34e-05 | 200 | 46 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 46 | 4 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 27 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 27 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Drug | cytochalasin B; Down 200; 20.8uM; MCF7; HT_HG-U133A_EA | 3.70e-05 | 187 | 46 | 5 | 1122_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.19e-05 | 192 | 46 | 5 | 3164_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.51e-05 | 195 | 46 | 5 | 1132_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 46 | 5 | 1662_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 5637_UP | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 7207_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 7486_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 7012_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.85e-05 | 198 | 46 | 5 | 914_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 7023_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 3170_DN | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 2332_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 1466_DN | |
| Drug | AC1L1UOE | 7.80e-05 | 41 | 46 | 3 | CID000010191 | |
| Disease | Skin Abnormalities | 1.68e-04 | 13 | 44 | 2 | C0037268 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.91e-04 | 17 | 44 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Pilocytic Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0334583 | |
| Disease | Cerebral Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0750936 | |
| Disease | Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 6.38e-04 | 25 | 44 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 6.38e-04 | 25 | 44 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 6.90e-04 | 26 | 44 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 6.90e-04 | 26 | 44 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 6.90e-04 | 26 | 44 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 7.45e-04 | 27 | 44 | 2 | C0334579 | |
| Disease | Malignant neoplasm of breast | 9.79e-04 | 1074 | 44 | 7 | C0006142 | |
| Disease | facial hair thickness measurement | 1.05e-03 | 32 | 44 | 2 | EFO_0007823 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRRHKDRLAGKTPKP | 311 | Q66K41 | |
| PPSPHSNRKKHRRKK | 536 | Q96P47 | |
| SNRKKHRRKKSTGTP | 541 | Q96P47 | |
| KKHKASKRSRHGPGR | 466 | P55198 | |
| VRGKHKHRKPTKPES | 1176 | Q5H9F3 | |
| FATGRPKKTKKRSHP | 416 | Q9Y4B4 | |
| SKAHRSRTKSSKEPP | 276 | Q14004 | |
| DSRRKKPKKGPSSHR | 16 | O75071 | |
| KPKKGPSSHRLLRTE | 21 | O75071 | |
| PHPATTRGDRKQKKR | 201 | Q9Y2D1 | |
| PKSKIPSKNVRHRGR | 1396 | Q9HCM3 | |
| KSSRIKRSPKPRRKH | 1591 | Q9HCM3 | |
| HTPMGKKSRRPSAKS | 2096 | Q04721 | |
| HGSHSPPKEKCKRKR | 361 | Q8NEM0 | |
| HKPLKKGSRTPSDRT | 1231 | Q92823 | |
| SAKKREHPRKPKAGD | 941 | Q5VYM1 | |
| RRSHRKRSQPKKPKP | 371 | O94953 | |
| RSKRHRGKSLKPPKK | 421 | Q96N16 | |
| GHSKYRLKKRRKTPG | 61 | P78563 | |
| TPRSGKDKRRSSKPR | 226 | Q75WM6 | |
| MSRRRKHDDSPSPKK | 1 | Q9NY74 | |
| KPKRRKKHAVASAAP | 126 | Q6UWH4 | |
| PASKKPRVHKRGSES | 2116 | Q3L8U1 | |
| PSSKRPSLHRLGKEK | 986 | Q76NI1 | |
| REHKGKKKTPSSPSL | 391 | Q96DZ5 | |
| DNVGKPKSRSPSRHK | 281 | Q08170 | |
| KNKEKKRPHTESPGR | 236 | A6NNA2 | |
| HDNRRRSRSKSKPPK | 131 | Q15287 | |
| RSKRKPPHGGERKEK | 981 | Q96KN7 | |
| ESESKKRKHRSPTPK | 221 | Q9UQ35 | |
| KRKHRSPTPKSKRKS | 226 | Q9UQ35 | |
| KDKKRKRSRSTTPAP | 241 | Q9UQ35 | |
| KSGHRKRASKSPRKT | 556 | P30414 | |
| RKDTPKTKHKSLPRT | 1256 | Q9HCM1 | |
| AEARKSHSPVKRPRK | 46 | P78549 | |
| ASPKATSKPKHRHRK | 1511 | Q9NTG1 | |
| KKKGHIPTPSRSESK | 356 | Q8TC41 | |
| KTESGTHPKGTRRKK | 766 | Q8IYB8 | |
| THPKGTRRKKKEPDS | 771 | Q8IYB8 | |
| STPKRRHKKKSLPGG | 286 | Q9HB58 | |
| RHCPGGKRTPKAKEK | 201 | Q6UXX9 | |
| TPLRKHKKKGRQSRP | 56 | P55201 | |
| PHGKPRDKGRSCKRS | 191 | Q8NHH1 | |
| SHPLRELKKSKGGKR | 291 | Q15697 | |
| SRSPSPRRHKKEKKK | 366 | Q05519 | |
| GRPIHKGKSKKTSTR | 356 | Q86V40 | |
| KSKETGRTHKPDKLR | 426 | A6NKC9 | |
| SPERSKKSHKKSRRG | 296 | Q8NAV1 | |
| PTKRTHRKKPKRGTC | 281 | Q7Z5U6 | |
| QPPRKKSHRVSGKER | 2496 | Q96JG9 | |
| SPKRKKRHSRSRSPT | 551 | Q8TF01 | |
| CRKEKKTKGPSRHPS | 261 | Q86YD3 | |
| SKGTPRRKHGKRPNK | 1226 | Q9NR99 |